Results 241 to 250 of about 114,702 (262)
Some of the next articles are maybe not open access.

The adenosine pathway in immuno-oncology

Nature Reviews Clinical Oncology, 2020
Bertrand Allard   +2 more
exaly  

NTRK fusion-positive cancers and TRK inhibitor therapy

Nature Reviews Clinical Oncology, 2018
Emiliano Cocco   +2 more
exaly  

Efficacy and Safety of the Bruton Tyrosine Kinase Inhibitor Ibrutinib in Patients with Hairy Cell Leukemia: Stage 1 Results of a Phase 2 Study

, 2016
Jeffrey A Jones   +10 more
semanticscholar   +1 more source

Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?

Nature Reviews Clinical Oncology, 2016
Fausto Castagnetti, Michele Baccarani
exaly  

Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton's Tyrosine Kinase Inhibitor in Early Clinical Development.

Journal of Medicinal Chemistry, 2018
J. Crawford   +24 more
semanticscholar   +1 more source

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Nature Reviews Cancer, 2019
Jonathan J Havel   +2 more
exaly  

Biochemistry of Peroxynitrite and Protein Tyrosine Nitration

Chemical Reviews, 2018
Gerardo Ferrer-Sueta   +2 more
exaly  

Home - About - Disclaimer - Privacy